FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37497743> ?p ?o ?g. }

• Q37497743 description "article científic" @default.
• Q37497743 description "article scientifique" @default.
• Q37497743 description "articolo scientifico" @default.
• Q37497743 description "artigo científico" @default.
• Q37497743 description "artículu científicu espublizáu en 2016" @default.
• Q37497743 description "bilimsel makale" @default.
• Q37497743 description "scientific article published on February 2016" @default.
• Q37497743 description "vedecký článok" @default.
• Q37497743 description "vetenskaplig artikel" @default.
• Q37497743 description "videnskabelig artikel" @default.
• Q37497743 description "vědecký článek" @default.
• Q37497743 description "wetenschappelijk artikel" @default.
• Q37497743 description "wissenschaftlicher Artikel" @default.
• Q37497743 description "наукова стаття, опублікована в лютому 2016" @default.
• Q37497743 description "научни чланак" @default.
• Q37497743 description "գիտական հոդված հրատարակված 2016 թվականի փետրվարին" @default.
• Q37497743 description "مقالة علمية نشرت في فبراير 2016" @default.
• Q37497743 name "The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage" @default.
• Q37497743 name "The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage" @default.
• Q37497743 name "The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage" @default.
• Q37497743 name "The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy" @default.
• Q37497743 type Item @default.
• Q37497743 label "The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage" @default.
• Q37497743 label "The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage" @default.
• Q37497743 label "The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage" @default.
• Q37497743 label "The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy" @default.
• Q37497743 prefLabel "The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage" @default.
• Q37497743 prefLabel "The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage" @default.
• Q37497743 prefLabel "The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage" @default.
• Q37497743 prefLabel "The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy" @default.
• Q37497743 P1154 Q37497743-2E65BD28-86B3-46DA-A2DB-42566A147B25 @default.
• Q37497743 P1433 Q37497743-BDF3DB5C-63CD-4E2F-B481-42911E526F55 @default.
• Q37497743 P1476 Q37497743-941830EA-2B1F-44CC-BEAE-260B7342F925 @default.
• Q37497743 P2093 Q37497743-0660E771-7DB8-4F2A-9AED-6381C048A1DF @default.
• Q37497743 P2093 Q37497743-20AC1024-EA4A-4EE8-80A4-E213E54DBC9F @default.
• Q37497743 P2093 Q37497743-3BBB733A-CD1E-49C5-A468-5FBD9F653DF0 @default.
• Q37497743 P2093 Q37497743-412181C8-B787-4E9F-857D-78F0966C43E5 @default.
• Q37497743 P2093 Q37497743-7AF0E2F7-1A6C-4C94-9120-3B1DD73A4778 @default.
• Q37497743 P2093 Q37497743-7B5D4EF0-1041-4E97-89D9-0F94F79F16EF @default.
• Q37497743 P2093 Q37497743-7C69D792-BBB1-466E-8F90-B287F646F616 @default.
• Q37497743 P2093 Q37497743-CEF8C32A-FBAF-42A8-85C6-D8FE38123726 @default.
• Q37497743 P2093 Q37497743-DCB177FE-D2F4-4905-A76A-18BCBF70E013 @default.
• Q37497743 P2093 Q37497743-E561EF8A-5992-42FA-B7D7-41629FB09A9F @default.
• Q37497743 P2507 Q37497743-F3899968-7A78-4102-BDC9-CD924DA96BA3 @default.
• Q37497743 P2860 Q37497743-147B6151-304E-465B-8AB0-612678F1309D @default.
• Q37497743 P2860 Q37497743-17C3CCF6-C374-4624-89B1-DA97F5620937 @default.
• Q37497743 P2860 Q37497743-2E076E0C-BE74-48B8-A525-0689E3D3315D @default.
• Q37497743 P2860 Q37497743-412F09FA-18AD-4B1D-B37A-555AD517A666 @default.
• Q37497743 P2860 Q37497743-4991A2A9-6478-4A50-8A04-72BCEF84EE65 @default.
• Q37497743 P2860 Q37497743-4EEB835E-0094-429E-A34B-5C19753E7085 @default.
• Q37497743 P2860 Q37497743-522BF844-2F18-4FEF-9D62-A68E9CA7F2A0 @default.
• Q37497743 P2860 Q37497743-5CB881C6-B3D2-4743-9D79-83D1A8F3637D @default.
• Q37497743 P2860 Q37497743-63009314-8DFB-42DE-BC80-D25A429867FB @default.
• Q37497743 P2860 Q37497743-68580958-6CA8-4D55-B832-B75A8119F773 @default.
• Q37497743 P2860 Q37497743-95259B98-7777-4A7A-851D-E1FA0DA62339 @default.
• Q37497743 P2860 Q37497743-A7BA0B69-0292-45C4-BD5D-2B8F305EFFD5 @default.
• Q37497743 P2860 Q37497743-B8DA66F3-961A-4C05-9BC4-8F74794C147D @default.
• Q37497743 P2860 Q37497743-BB3D30DF-8581-4AF2-B36F-D36DC3EA1A08 @default.
• Q37497743 P2860 Q37497743-DC3EE452-B3A8-419D-9D36-19EFE67D3701 @default.
• Q37497743 P2860 Q37497743-EAECA780-8D8B-4D44-9884-55AB1F37CAE3 @default.
• Q37497743 P2888 Q37497743-936D3A9B-E661-4AA0-AE71-608624D460A8 @default.
• Q37497743 P304 Q37497743-59ACCCA2-2B21-44AE-9EAA-BB79798426A2 @default.
• Q37497743 P31 Q37497743-C40087DB-1DDF-46CB-A314-485F969AE00A @default.
• Q37497743 P356 Q37497743-CBDA4B79-C86E-40CD-97AD-D11D3C023109 @default.
• Q37497743 P478 Q37497743-8FC0EDC0-B523-4AF1-B615-E2359D18616C @default.
• Q37497743 P50 Q37497743-0E5BA1EF-AC1D-442B-B63A-4B416D2FB7B7 @default.
• Q37497743 P50 Q37497743-759732EC-3436-4225-8918-EFBC9F374575 @default.
• Q37497743 P50 Q37497743-7DE41E14-8C0B-440D-94C2-4BB4AFDFCBBC @default.
• Q37497743 P5530 Q37497743-71184CF5-FEB1-4F87-B0CA-30E1B2E40FDF @default.
• Q37497743 P577 Q37497743-6C13FCFC-C413-4029-8482-147D141B8A10 @default.
• Q37497743 P6179 Q37497743-62916007-FFCA-44DD-9D20-D8484DA3FA9C @default.
• Q37497743 P6409 Q37497743-073AC9C3-1BA5-422E-B9B7-A6B45535856B @default.
• Q37497743 P698 Q37497743-0136DF80-2D93-4AB4-9A6C-94BC528457C8 @default.
• Q37497743 P921 Q37497743-75FF3EC0-6AE3-4631-AE4F-6956638CBBE7 @default.
• Q37497743 P921 Q37497743-7D359DAD-D2DB-4106-A945-66FD997554A5 @default.
• Q37497743 P932 Q37497743-795BF775-7F5E-4D45-B3D9-3FDF3E457724 @default.
• Q37497743 P953 Q37497743-C6FD38D1-6878-47D5-9B22-949F3773F013 @default.
• Q37497743 P356 S40814-016-0046-2 @default.
• Q37497743 P698 27965826 @default.
• Q37497743 P1154 "2-s2.0-84992162078" @default.
• Q37497743 P1433 Q27727225 @default.
• Q37497743 P1476 "The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection" @default.
• Q37497743 P2093 "A Striha" @default.
• Q37497743 P2093 "B Naidu" @default.
• Q37497743 P2093 "C M Lowe" @default.
• Q37497743 P2093 "D R Baldwin" @default.
• Q37497743 P2093 "F Collinson" @default.
• Q37497743 P2093 "J Hewison" @default.
• Q37497743 P2093 "K Franks" @default.
• Q37497743 P2093 "L McParland" @default.
• Q37497743 P2093 "M P Snee" @default.
• Q37497743 P2093 "W M Gregory" @default.
• Q37497743 P2507 Q42353451 @default.
• Q37497743 P2860 Q30656342 @default.
• Q37497743 P2860 Q33997877 @default.
• Q37497743 P2860 Q34121705 @default.
• Q37497743 P2860 Q34204947 @default.
• Q37497743 P2860 Q34721402 @default.
• Q37497743 P2860 Q37480195 @default.
• Q37497743 P2860 Q38330179 @default.

• next